Résumé
Le choix d’un score de symptômes et/ou de qualité de vie dans les incontinences chez l’homme est fonction :
-
de l’existence d’autres symptômes urinaires associés ;
-
du type de population étudiée (neurologique/non neurologique) ;
-
des propriétés de mesures du questionnaire:
-
○fiabilité et validité de construction : étude discriminative comparative de population,
-
sensibilité aux changements et validité de construction : essais thérapeutiques et suivi clinique ;
-
-
du niveau de validation psychométrique : performance du questionnaire ;
-
de l’existence d’une forme courte.
Preview
Unable to display preview. Download preview PDF.
Références
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104: 1374–1379
Abrams P, Kelleher CJ, Kerr LA, Rogers RG (2000) Overactive bladder significantly affects quality of life. Am J Manag Care 6: S580–S590
Brown JS, McGhan WF, Chokroverty S (2000) Comorbidities associated with overactive bladder. Am J Manag Care 6:S574–S579
Wagner TH, Hu TW, Bentkover J, et al. (2002) Health-related consequences of overactive bladder. Am J Manag Care 8: S598–S607
Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118: 622–629
Amarenco G, Bayle B, Lagauche D, et al. (2000) Construction et validation des échelles de qualité de vie. Ann Readapt Med Phys 43: 263–269
Donovan J, Bosch R, Gotoh M, et al. (2005) Symptom and quality of life assessment.In: Abrams P, Cardozo L, Khoury S, Wein A, (2004) eds. Incontinence: Proceedings of the Third International Consultation on Incontinence, June 26–29. Third ed. Plymouth, United Kingdom: Health Publication Ltd 519–584
Black N, Griffiths J, Pope C (1996) Development of a symptom severity index and a symptom impact index for stress incontinence in women. Neurourol Urodyn 15: 630–640
Boch R (1996) Use of international Prostate Symptom Score (IPSS) in epidemiological studies and clinical practice 263–274
Haab F, Richard F, Amarenco G, et al. (2008). Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Urology 71: 646–656
Avery K, Donovan J, Peters TJ et al. (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23: 322–330
Brookes ST, Donovan JL, Wright M, et al. (2004) A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol 191: 73–82
Hansen BJ, Flyger H, Brasso K, et al. (1995) Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 76: 451–458
Schulman CC, Zlotta AR (1995) Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology 45: 28–33
van Venrooij GE, Boon TA, de Gier RP (1995) International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 153: 1516–1519
Donovan J, Abrams P, Peters TJ et al. (1996) The ICS-BPH study: the psychometric validity and reliability of the ICS male questionnaire. 77: 554–562
Hansen B, Mortensen S, Mensink H et al. (1998) Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group. Br J Urol 81: 36–41
Barry MJ, Fowler FJ Jr, O’Leary MP et al. (1995) Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association. Med Care 33: AS145–AS155
Lukacs B, McCarthy C, Grange JC (1993) Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General Practice. Eur Urol 24: 34–40
Wagner TH, Patrick DL, Bavendam TG et al. (1996) Quality of life of persons with urinary incontinence: development of a new measure. Urology 47: 67–71 discussion 71–62
Moore KN, Jensen L (2000) Testing of the Incontinence Impact Questionnaire (IIQ-7) with men after radical prostatectomy. J Wound Ostomy Continence Nurs 27: 304–312
Bonniaud V, Bryant D, Parratte B, Guyatt G (2008) Development and Validation of the Short Form of a Urinary Quality of Life Questionnaire: SF-Qualiveen. J Urol accepted
Boyle P (1997) Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale. Eur Urol 32Suppl 2: 50–52
Lukacs B, Comet D, Grange JC, Thibault P (1997) Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General Practice. Br J Urol 80: 722–730
Patrick DL, Martin ML, Bushnell DM et al. (1999) Cultural adaptation of a quality-of-life measure for urinary incontinence. Eur Urol 36: 427–435
Kelleher CJ, Cardozo L, Chapple CR et al. (2005) Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int 95: 81–85
Reese PR, Pleil AM, Okano GJ, Kelleher CJ (2003) Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder. Qual Life Res 12: 427–442
Conway K, Uzun V, Marrel A et al. (1999) Linguistic validation of the King’s Health Questionnaire (KHQ) in eight languages (abstract). Value Health 2: 204
Uebersax JS, Wyman JF, Shumaker SA et al. (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14: 131–139
Haab F, Trockman BA, Zimmern PE, Leach GE (1997) Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of followup. J Urol 158: 435–439
Bonniaud V, Bryant D, Parratte B et al. (2006) Validation of a urinary-disorder specific instrument for use in clinical trials in multiple sclerosis. Arch Phys Med Rehabil 87: 1661–1663
Bonniaud V, Bryant D, Pilati C et al. (2010) Italian version of Qualiveen-30: Cultural Adaptation of a Neurogenic Urinary-Disorder Specific Instrument Neurourol Urodyn Accepted in April.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag France
About this chapter
Cite this chapter
Bonniaud, V. (2011). Les scores de symptômes et de qualité de vie. In: Les incontinences urinaires de l’homme. Springer, Paris. https://doi.org/10.1007/978-2-287-99160-8_6
Download citation
DOI: https://doi.org/10.1007/978-2-287-99160-8_6
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-99159-2
Online ISBN: 978-2-287-99160-8
eBook Packages: MedicineMedicine (R0)